GB0207323D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0207323D0
GB0207323D0 GB0207323A GB0207323A GB0207323D0 GB 0207323 D0 GB0207323 D0 GB 0207323D0 GB 0207323 A GB0207323 A GB 0207323A GB 0207323 A GB0207323 A GB 0207323A GB 0207323 D0 GB0207323 D0 GB 0207323D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0207323A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GB0207323A priority Critical patent/GB0207323D0/en
Publication of GB0207323D0 publication Critical patent/GB0207323D0/en
Priority to TW096130334A priority patent/TW200813014A/en
Priority to TW092106024A priority patent/TWI324597B/en
Priority to JP2003580299A priority patent/JP3891493B2/en
Priority to ES03710015T priority patent/ES2346135T3/en
Priority to EP03710015A priority patent/EP1487806B1/en
Priority to BR0308670-4A priority patent/BR0308670A/en
Priority to US10/508,675 priority patent/US20050215574A1/en
Priority to PCT/GB2003/001306 priority patent/WO2003082831A1/en
Priority to SI200331852T priority patent/SI1487806T1/en
Priority to CN 200710004468 priority patent/CN101003515A/en
Priority to PL372889A priority patent/PL214880B1/en
Priority to CNB038117398A priority patent/CN100439344C/en
Priority to DE60333262T priority patent/DE60333262D1/en
Priority to IL16413503A priority patent/IL164135A0/en
Priority to MXPA04009486A priority patent/MXPA04009486A/en
Priority to KR1020047015473A priority patent/KR101006947B1/en
Priority to CA2479642A priority patent/CA2479642C/en
Priority to DK03710015.3T priority patent/DK1487806T3/en
Priority to AU2003214443A priority patent/AU2003214443B8/en
Priority to MYPI20031118A priority patent/MY158054A/en
Priority to RU2004131683/04A priority patent/RU2345989C2/en
Priority to NZ535014A priority patent/NZ535014A/en
Priority to UA20041008762A priority patent/UA78302C2/en
Priority to PT03710015T priority patent/PT1487806E/en
Priority to AT03710015T priority patent/ATE473215T1/en
Priority to ARP030101122A priority patent/AR039203A1/en
Priority to UY27742A priority patent/UY27742A1/en
Priority to SA03240080A priority patent/SA03240080B1/en
Priority to ZA200407416A priority patent/ZA200407416B/en
Priority to IL164135A priority patent/IL164135A/en
Priority to IS7469A priority patent/IS2855B/en
Priority to NO20044325A priority patent/NO329542B1/en
Priority to HK05103509.3A priority patent/HK1070888A1/en
Priority to HK05111553.1A priority patent/HK1079521A1/en
Priority to JP2006102765A priority patent/JP2006249093A/en
Priority to ZA200610455A priority patent/ZA200610455B/en
Priority to US12/147,250 priority patent/US20080269487A1/en
Priority to US12/706,675 priority patent/US8399667B2/en
Priority to CY20101100824T priority patent/CY1111039T1/en
Priority to US13/608,092 priority patent/US20130005727A1/en
Ceased legal-status Critical Current

Links

GB0207323A 2002-03-28 2002-03-28 Compounds Ceased GB0207323D0 (en)

Priority Applications (41)

Application Number Priority Date Filing Date Title
GB0207323A GB0207323D0 (en) 2002-03-28 2002-03-28 Compounds
TW096130334A TW200813014A (en) 2002-03-28 2003-03-19 Quinazoline derivatives
TW092106024A TWI324597B (en) 2002-03-28 2003-03-19 Quinazoline derivatives
AT03710015T ATE473215T1 (en) 2002-03-28 2003-03-26 4-ANILINEQUINAZOLINE DERIVATIVES AS ANTIPROLIFERATIVE ACTIVE INGREDIENTS
MYPI20031118A MY158054A (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
NZ535014A NZ535014A (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
EP03710015A EP1487806B1 (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
BR0308670-4A BR0308670A (en) 2002-03-28 2003-03-26 Quinazoline derivative or a pharmaceutically acceptable salt thereof, process for preparing it, pharmaceutical composition, use of said derivative or salt thereof, method for producing an antiproliferative effect on a warm-blooded animal in need of such treatment, and , compound or a salt thereof.
US10/508,675 US20050215574A1 (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
PCT/GB2003/001306 WO2003082831A1 (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
SI200331852T SI1487806T1 (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
CN 200710004468 CN101003515A (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
PL372889A PL214880B1 (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
CNB038117398A CN100439344C (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
DE60333262T DE60333262D1 (en) 2002-03-28 2003-03-26 4-anilinchinazolinderivate als antiproliferative wirkstoffe
IL16413503A IL164135A0 (en) 2002-03-28 2003-03-26 4-Anilino quinazoline derivatives as antirpoliferative agents
MXPA04009486A MXPA04009486A (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents.
KR1020047015473A KR101006947B1 (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
CA2479642A CA2479642C (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
DK03710015.3T DK1487806T3 (en) 2002-03-28 2003-03-26 4-aniline quinazoline derivatives as antiproliferative agents
AU2003214443A AU2003214443B8 (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
JP2003580299A JP3891493B2 (en) 2002-03-28 2003-03-26 4-anilinoquinazoline derivatives as antitumor agents
RU2004131683/04A RU2345989C2 (en) 2002-03-28 2003-03-26 Derivatives of 4-anilino-benzodiazine, method of obtaining them (versions) pharmaceutical composition, method of inhibiting their proliferative action and method of treating cancer in warm-blooded animal
ES03710015T ES2346135T3 (en) 2002-03-28 2003-03-26 DERIVATIVES OF 4-ANILINO QUINAZOLINA AS ANTIPROLIFERATIVE AGENTS.
UA20041008762A UA78302C2 (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
PT03710015T PT1487806E (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
ARP030101122A AR039203A1 (en) 2002-03-28 2003-03-28 QUINAZOLINE DERIVATIVES
UY27742A UY27742A1 (en) 2002-03-28 2003-03-28 QUINAZOLINE DERIVATIVES
SA03240080A SA03240080B1 (en) 2002-03-28 2003-04-16 4-ANILINO QUINAZOLINE derivatives AS ANTIPROLIFERATIVES AGENTS
ZA200407416A ZA200407416B (en) 2002-03-28 2004-09-15 4-anilino quinazoline derivatives as antiproliferative agents
IL164135A IL164135A (en) 2002-03-28 2004-09-19 4-anilino quinazoline derivatives as antiproliferative agents, process for their preparation, pharmaceutical compositions containing such derivatives and use thereof for the preparation of medicaments for the treatment of cancer
IS7469A IS2855B (en) 2002-03-28 2004-09-24 4-anilinoquinazoline derivatives as a propagating agent
NO20044325A NO329542B1 (en) 2002-03-28 2004-10-12 4-Anilinoquinazoline Derivatives, Methods for Preparing Such, Pharmaceutical Preparations Containing Such, Such Compounds for Use as a Medication, and Use of Such Compounds for the Preparation of Medication for the Treatment of Disease
HK05103509.3A HK1070888A1 (en) 2002-03-28 2005-04-25 4-anilino quinazoline derivatives as antiproliferative agents
HK05111553.1A HK1079521A1 (en) 2002-03-28 2005-12-15 4-anilino quinazoline derivatives as antiproliferative agents
JP2006102765A JP2006249093A (en) 2002-03-28 2006-04-04 4-anilinoquinazoline derivative as antineoplastic agent
ZA200610455A ZA200610455B (en) 2002-03-28 2006-12-13 4-Anilino Quinazoline derivatives as antiproliferative agents
US12/147,250 US20080269487A1 (en) 2002-03-28 2008-06-26 4-anilino quinazoline derivatives as antiproliferative agents
US12/706,675 US8399667B2 (en) 2002-03-28 2010-02-16 4-anilino quinazoline derivatives as antiproliferative agents
CY20101100824T CY1111039T1 (en) 2002-03-28 2010-09-09 4-ANILINO KINAZOLIN DERIVATIVE AS ANTI-COLLAPABLE FACTORS
US13/608,092 US20130005727A1 (en) 2002-03-28 2012-09-10 Quinazoline derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0207323A GB0207323D0 (en) 2002-03-28 2002-03-28 Compounds

Publications (1)

Publication Number Publication Date
GB0207323D0 true GB0207323D0 (en) 2002-05-08

Family

ID=9933889

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0207323A Ceased GB0207323D0 (en) 2002-03-28 2002-03-28 Compounds

Country Status (3)

Country Link
CN (1) CN101003515A (en)
GB (1) GB0207323D0 (en)
ZA (2) ZA200407416B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102060875B (en) * 2009-11-18 2014-03-12 天津药物研究院 Quinazoline derivative, and preparation method and application thereof
CN102796109B (en) * 2011-05-23 2015-10-07 复旦大学 4-Aminoquinazolines compounds and its production and use
CN103172641B (en) * 2011-12-20 2014-06-11 钱卫 Heterocyclic amino and alkoxy-replaced quinazoline derivative and application thereof
CN104530063B (en) 2015-01-13 2017-01-18 北京赛特明强医药科技有限公司 Quinazoline and heterocyclic ring compounds, preparing method of compounds, and application of compounds serving as epidermal growth factor receptor inhibitors used for treating cancer
CN105837586B (en) * 2015-12-14 2018-02-13 北京赛特明强医药科技有限公司 Dioxane and quinazoline aminated compounds and preparation method thereof and the application as epidermal growth factor receptor inhibitor
UY37935A (en) * 2017-10-18 2020-03-31 Spectrum Pharmaceuticals Inc INHIBITORS OF TYROSINE KINASES FROM THE FAMILY OF EGFR MUTANTS
KR20200131265A (en) * 2018-03-14 2020-11-23 치아타이 티안큉 파마수티컬 그룹 주식회사 Quinoline derivatives for treating nasopharyngeal cancer

Also Published As

Publication number Publication date
CN101003515A (en) 2007-07-25
ZA200610455B (en) 2007-11-28
ZA200407416B (en) 2007-03-28

Similar Documents

Publication Publication Date Title
GB0212785D0 (en) Compounds
EP1558585A4 (en) Neurologically-active compounds
GB0209022D0 (en) Compounds
GB0200283D0 (en) Compounds
AU2003216859A8 (en) Amidoacetonitrile compounds
GB0210762D0 (en) Compounds
GB0211418D0 (en) Compounds
GB0207323D0 (en) Compounds
GB0212399D0 (en) Compounds
GB0203778D0 (en) Compounds
GB0213011D0 (en) Compounds
GB0213122D0 (en) Compounds
GB0209244D0 (en) Compounds
GB0203811D0 (en) Compounds
AU2003275480A8 (en) Compounds
GB0206981D0 (en) Compounds
GB0209029D0 (en) Compounds
GB0203900D0 (en) Compounds
GB0210513D0 (en) Compounds
GB0209498D0 (en) Compounds
GB0209320D0 (en) Compounds
GB0212398D0 (en) Compounds
GB0209030D0 (en) Compounds
GB0211133D0 (en) Compounds
GB0212401D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)